Use of Severity Grades to Characterize Histopathologic Changes

Toxicologic Pathology

Volumn 46, Issue 3, 2018, Pages 256-265

  Schafer, Kenneth A ^a   Eighmy, John ^b   Fikes, James D ^c   Halpern, Wendy G ^d   Hukkanen, Renee R ^e   Long, Gerald G ^f   Meseck, Emily K ^g   Patrick, Daniel J ^h   Thibodeau, Michael S ⁱ   Wood, Charles E ^j   Francke, Sabine ^k  

^a Vet Path Services Inc   (United States)

^b 206 Carnegie Center   (United States)

^c BIOGEN   (United States)

^d GENENTECH INC   (United States)

^e EISAI INC   (United States)

^f EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

^g NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^h MPI RESEARCH   (United States)

ⁱ BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^j U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^k CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

more..

Author keywords

adversity; hazard; histopathology; risk assessment; severity grades; severity scores

Indexed keywords

ARTICLE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; HEALTH CARE POLICY; HISTOPATHOLOGY; HUMAN; MICROSCOPY; NONHUMAN; PATHOLOGIST; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; TOXICITY TESTING; ANIMAL; PATHOLOGY; STANDARDS; TOXICOLOGY;

ANIMALS; HUMANS; PATHOLOGY; TOXICOLOGY;

EID: 85043679031     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623318761348     Document Type: Article

References (25)

1. Adams E. T., Crabbes T. A., (2013). Basic approaches in anatomic toxicologic pathology. In Haschek and Rousseaux’s Handbook of Toxicologic Pathology (Haschek W. M., Rousseaux C. G., Wallig M. A., Bolon B., Ochoa R., eds.), pp. 164–65. Academic Press, Amsterdam, the Netherlands.
2. Crissman J. W., Goodman D. G., Hildebrandt P. K., Maronpot R. R., Prater D. A., Riley J. H., Seaman W. J., Thake D. C., (2004). Best practices guideline: Toxicologic histopathology. Toxicol Pathol 32, 126–31.
3. Engelhardt J. A., Gries C. L., Long G. G., (1993). Incidence of spontaneous neoplastic and nonneoplastic lesions in Charles River CD-1 mice varies with breeding origin. Toxicol Pathol 21, 538–41.
4. Gibson-Corley K. N., Olivier A. K., Meyerholz D. K., (2013). Principles for valid histopathologic scoring in research. Vet Pathol 50, 1007–15.
5. Hard G. C., Betz L. J., Seely J. C., (2012). Association of advanced chronic progressive nephropathy (CPN) with renal tubule tumors and precursor hyperplasia in control F344 rats from two-year carcinogenicity studies. Toxicol Pathol 40, 473–81.
6. Holland T., Holland C., (2011a). Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe it to treatment?). Toxicol Pathol 39, 569–75.
7. Holland T., Holland C., (2011b). Response to Letter to Editor by Dr. J. C. Wolf on “Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe it to treatment?).” Toxicol Pathol 39, 1138.
8. International Organization for Standardization. (2016). ISO 10993-6: 2016 Biological evaluation of medical devises—Part 6 tests for local effects after implantation. Accessed January 1, 2018. https://www.iso.org/standard/61089.html.
9. Kaufmann W., Bader R., Ernst H., Harada T., Hardisty J., Kittel B., Kolling A.. (2009). 1st International ESTP Expert Workshop: “Larynx squamous metaplasia.” A re-consideration of morphology and diagnostic approaches in rodent studies and its relevance for human risk assessment. Exp Toxicol Pathol 61, 591–603.
10. Kerlin R., Bolon B., Burkhardt J., Francke S., Greaves P., Meador V., Popp J., (2016). Scientific and regulatory policy committee: Recommended (“best”) practices for determining, communicating, and using adverse effect data from nonclinical studies. Toxicol Pathol 44, 147–62.
11. Levin S., (2011). Concerning the analysis of unbiased histopathology data. Toxicol Pathol 39, 1139.
12. Long G. G., Hardisty J. F., (2012). Regulatory forum opinion piece: Thresholds in toxicologic pathology. Toxicol Pathol 40, 1079–81.
13. Mann P. C., Hardisty J. H., (2014). Pathology working groups. Toxicol Pathol 42, 283–84.
14. Mann P. C., Vahle J., Keenan C. M., Baker J. F., Bradley A. E., Goodman D. G., Harada T.. (2012). International harmonization of toxicologic pathology nomenclature: An overview and review of basic principles. Toxicol Pathol 40, 7s–13s.
15. Markovits J. E., Bouchard P. R., Clarke C. J., McMartin D. N., (2013). Introduction to toxicologic pathology. In Toxicologic Pathology: Nonclinical Safety Assessment (Sahota P. S., Popp J. A., Hardisty J. F., Gopinath C., eds.), pp. 77–96. CRC Press, Boca Raton, FL.
16. McConnell E. E., Davis J. M., (2002). Quantification of fibrosis in the lungs of rats using a morphometric method. Inhal Toxicol 14, 263–72.
17. Morton D., Kemp R. K., Francke-Carroll S., Jensen K., McCartney J., Monticello T. M., Perry R.. (2006). Best practices for reporting pathology interpretations within GLP toxicology studies. Toxicol Pathol 34, 806–9.
18. Morton D., Sellers R. S., Barale-Thomas E., Bolon B., George C., Hardisty J. F., Irizarry A.. (2010). Recommendations for pathology peer review. Toxicol Pathol 38, 1118–27.
19. Palazzi X., Burkhardt J. E., Caplain H., Dellarco V., Fant P., Foster J. R., Francke S.. (2016). Characterizing “adversity” of pathology findings in nonclinical toxicity studies: Results from the 4th ESTP international expert workshop. Toxicol Pathol 44, 810–24.
20. Shackelford C., Long G., Wolf J., Okerberg C., Herbert R., (2002). Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol Pathol 30, 93–96.
21. Ward J. M., Thoolen B., (2011). Grading of lesions. Toxicol Pathol 39, 745–46.
22. Wolf J. C., (2011). Counterpoint to “Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe to treatment?).” Toxicol Pathol 39, 1017–19.
23. Wolf J. C., Maack G., (2017). Evaluating the credibility of histopathology data in environmental endocrine toxicity studies. Environ Toxicol Chem 36, 601–11.
24. Wolf J. C., Ruehl-Fehlert C., Segner H. E., Weber K., Hardisty J. F., (2014). Pathology working group review of histopathologic specimens from three laboratory studies of diclofenac in trout. Aquat Toxicol 146, 127–36.
25. Zbinden G., (ed.) (1976). The role of pathology in toxicity testing In Progress in Toxicology, pp. 8–18. Springer-Verlag, Berlin, Germany.